Vanta Bioscience Balance Sheet Health
Financial Health criteria checks 0/6
Vanta Bioscience has a total shareholder equity of ₹93.4M and total debt of ₹658.2M, which brings its debt-to-equity ratio to 704.5%. Its total assets and total liabilities are ₹856.5M and ₹763.0M respectively.
Key information
704.5%
Debt to equity ratio
₹658.21m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹1.64m |
| Equity | ₹93.44m |
| Total liabilities | ₹763.02m |
| Total assets | ₹856.45m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540729's short term assets (₹174.6M) do not cover its short term liabilities (₹234.8M).
Long Term Liabilities: 540729's short term assets (₹174.6M) do not cover its long term liabilities (₹528.2M).
Debt to Equity History and Analysis
Debt Level: 540729's net debt to equity ratio (702.7%) is considered high.
Reducing Debt: 540729's debt to equity ratio has increased from 55.2% to 704.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 540729 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 540729 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 2.6% each year